AYTU — Aytu Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapTurnaround

Annual balance sheet for Aytu Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	49.6	19.4	23	20	31
Net Total Accounts Receivable
Net Total Receivables	28.2	21.7	28.9	23.6	31.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	105	59.9	72.8	61.9	79.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.7	6.3	3.87	1.52	1.59
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	266	138	136	118	124
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	109	64.4	69	62.2	63.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	128	91.5	97.1	90.4	105
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	138	46.1	39.4	27.7	19
Total Liabilities & Shareholders' Equity	266	138	136	118	124
Total Common Shares Outstanding
Total Preferred Shares Outstanding